A comparative study of morphine stimulation and biphalin inhibition of human glioblastoma T98G cell proliferation in vitro

Peptides

Volumn 31, Issue 8, 2010, Pages 1606-1612

  Lazarczyk, Marzena ^a   Matyja, Ewa ^a   Lipkowski, Andrzej W ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Biphalin; Glioblastoma; Morphine; Opioid receptor

Indexed keywords

BIPHALIN; KI 67 ANTIGEN; MORPHINE; OPIATE RECEPTOR;

ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL;

EID: 78249260313     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.05.002     Document Type: Article

References (24)

1. Alvarez VA, Arttamangkul S, Dang V, Salem A, Whistler JL, Von Zastrow M, et al. Mu opioid receptors: ligand-dependent activation of potassium conductance, desensitization, and internalization. J Neurosci 2002; 22:5769-5776
2. Donnelly S, Davis MP,Walsh D, Naughton M, World Health Organization. Morphine in cancer pain management: a practical guide. Support Care Cancer 2002; 10:13-35.
3. Doñate F, Parry GC, Shaked Y, Hensley H, Guan X, Beck I, et al. Pharmacology of the novel antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2): observation of a U-shaped dose.response curve in several preclinical models of angiogenesis and tumor growth. Clin Cancer Res 2008; 14:2137-2144
4. Endl E, Gerdes J. The Ki-67 protein: fascinating forms and an unknown function. Exp Cell Res 2000; 257:231-237
5. Gupta K, Kshirsagar S, Chang L, Schwartz R, Law PY, Yee D, et al. Morphine stimulates angiogenesis by activating proangiogenic and survivalpromoting signaling and promotes breast tumor growth. Cancer Res 2002; 62: 4491-4498
6. Hatzoglou A, Bakogeorgou E, Hatzoglou C, Martin PM, Castanas E. Antiproliferative and receptor binding properties of alpha- and beta-casomorphins in the T47D human breast cancer cell line. Eur J Pharmacol 1996; 310:217-223
7. Ishikawa M, Tanno K, Kamo A, Takayanagi Y, Sasaki K. Enhancement of tumor growth by morphine and its possible mechanism in mice. Biol Pharm Bull 1993; 16:762-766
8. Kawase M, Sakagami H, Furuya K, Kikuchi H, Nishikawa H, Motohashi N, et al. Cell death-inducing activity of opiates in human oral tumor cell lines. Anticancer Res 2002; 22:211-214
9. Kleihus P, Burge PC, Aldap KD, Brat DJ, Biernat W, Binger DD, et al. Glioblastoma. In: Louis DN, Ohgaki H, Wiestler OD, CaveneeWK,editors.WHO classification of tumours of the central nervous system. Lyon: International Agency for Research on Cancer; 2007. p. 33-46.
10. Kosson D, Klinowiecka A, Kosson P, Bonney I, Carr DB, Mayzner-Zawadzka E, et al. Intrathecal antinociceptive interaction between the NMDA antagonist ketamine and the opioids, morphine and biphalin. Eur J Pain 2008; 12:611-616
11. Lipkowski AW, Konecka AM, Sroczyńska I. Double-enkephalins- synthesis, activity on guinea-pig ileum, and analgesic effect. Peptides 1982; 3:697-700.
12. Lipkowski AW, Konecka AM, Sroczynska I, Przewłocki R, Stala L, Tam SW. Bivalent opioid peptide analogues with reduced distances between pharmacophores. Life Sci 1987; 40:2283-2288
13. Maneckjee R, Biswas R, Vonderhaar BK. Binding of opioids to human MCF-7 breast cancer cells and their effects on growth. Cancer Res 1990; 50:2234-2238
14. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000; 182:311-322
15. Singhal PC, Sharma P, Sanwal V, Prasad A, Kapasi A, Ranjan R, et al. Morphine modulates proliferation of kidney fibroblasts. Kidney Int 1998; 53:350-357
16. Singleton PA, Lingen MW, Fekete MJ, Garcia JG, Moss J. Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation. Microvasc Res 2006; 72:3-11.
17. Sueoka N, Sueoka E, Okabe S, Fujiki H. Anti-cancer effects of morphine through inhibition of tumour necrosis factor-alpha release and mRNA expression. Carcinogenesis 1996; 17:2337-2341
18. Tang JL, Lipkowski AW, Specter S. Molecular assessment of the potential combination therapy of cytokines with biphalin and AZT for Friend leukemia virus infection in vitro. Pharmacol Rep 2008; 60:190-198
19. Tegeder I, Geisslinger G. Opioids as modulators of cell death and survival.unraveling mechanisms and revealing new indications. Pharmacol Rev 2004; 56:351-369
20. Tegeder I, Grosch S, Schmidtko A, Haussler A, Schmidt H, Niederberger E, et al. G protein-independent G(1) cell cycle block and apoptosis with morphine in adenocarcinoma cells: involvement of p53 phosphorylation. Cancer Res 2003; 63:1846-1852.
21. Trescot AM, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Phys 2008; 11:133-153
22. Tsao P, Cao T, von Zastrow M. Role of endocytosis in mediating downregulation of G protein-coupled receptors. Trends Pharmacol Sci 2001; 22:91-96
23. Yamazaki M, Suzuki T, Narita M, Lipkowski AW. The opioid peptide analogue biphalin induces less physical dependence than morphine. Life Sci 2001; 69:1023-1028
24. Yin D, Woodruff M, Zhang Y, Whaley S, Miao J, Ferslew K, et al. Morphine promotes Jurkat cell apoptosis through pro-apoptotic FADD/P53 and anti apoptotic PI3K/Akt/NF-kappaB pathways. J Neuroimmunol 2006; 174:101-107